Global private equity and venture capital news and research

Posts Tagged ‘crown venture fund’

23 April 2014

Kala Pharmaceuticals scores $22.5m Series B

dollar envelope money Ysios Capital has led a $22.5m Series B round for Kala Pharmaceuticals, which is focused on developing ophthalmic products based on its mucus penetrating particle technology.

25 March 2013

Third Rock Ventures closes third fund at $516m

Boston-headquartered venture capital firm Third Rock Ventures has held a final close of $516m on its healthcare-focused Fund III, which was oversubscribed.

28 February 2013

Crown family’s VC fund backs Kala Pharmaceuticals

Crown Venture Fund has led an $11.5m Series A funding round for Kala Pharmaceuticals to advance its portfolio of innovative ophthalmic programmes.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016